FDA Import Refusal 98F-0075223-6/11/4 — The Procter & Gamble Company

The Procter & Gamble Company — FEI 3003601023

The FDA refused shipment 98F-0075223-6/11/4 from The Procter & Gamble Company (United States) on December 31, 2022. The refused product falls under Drugs and Biologics — CETYLPYRIDINIUM CHLORIDE (ANTI-INFECTIVE, TOPICAL). Cited charges: 2020,335,336,483 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 31, 2022
Country
United States
Product Category
Drugs and Biologics
Product Code
62FBL07 CETYLPYRIDINIUM CHLORIDE (ANTI-INFECTIVE, TOPICAL)
Charges
2020,335,336,483